1627P Long survivors after androgen deprivation therapy (ADT) with or without docetaxel for metastatic castration-sensitive prostate cancer (mCSPC): Long-term follow-up of GETUG-15

Autor: Blanchet-Deverly, S., Fizazi, K., Oudard, S., Gravis, G., Boughalem, E., Borchiellini, D., Foulon, S., Peyre Pradat, F., Beuzeboc, P., Mourey, L., Laguerre, B., Jacobs, M., Tosi, D., Priou, F., Sfumato, P., Massard, V.
Zdroj: In Annals of Oncology September 2024 35 Supplement 2:S982-S982
Databáze: ScienceDirect